Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2003;79:259-267; doi:10.1136/pmj.79.931.259
© 2003 BMJ Publishing Group Ltd and The Fellowship of Postgraduate Medicine.
Postgraduate Medical Journal 2003;79:259-267
© 2003 Fellowship of Postgraduate Medicine

REVIEW

Management of asthma in adults: current therapy and future directions

R H Green, C E Brightling, I D Pavord, A J Wardlaw

Institute for Lung Health, Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, Leicester

Correspondence to:
Correspondence to:
Dr Ruth Green, Institute for Lung Health, Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, Groby Road, Leicester, LE3 9QP, UK;
ruth.green{at}uhl-tr.nhs.uk

Asthma is increasing in prevalence worldwide and results in significant use of healthcare resources. Although most patients with asthma can be adequately treated with inhaled corticosteroids, an important number of patients require additional therapy and an increasing number of options are available. A further minority of patients develop severe persistent asthma which remains difficult to manage despite current pharmacological therapies. This review discusses the various treatment options currently available for each stage of asthma severity, highlights some of the limitations of current management, and outlines directions which may improve the management of asthma in the future.

Keywords: asthma

Abbreviations: FEV1, forced expiratory volume in one second; PEF, peak expiratory flow


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Sutcliffe, A, Kaur, D, Page, S, Woodman, L, Armour, C L, Baraket, M, Bradding, P, Hughes, J M, Brightling, C E (2006). Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics. Thorax 61: 657-662 [Abstract] [Full Text]  
  • Baelder, R., Fuchs, B., Bautsch, W., Zwirner, J., Kohl, J., Hoymann, H. G, Glaab, T., Erpenbeck, V., Krug, N., Braun, A. (2005). Pharmacological Targeting of Anaphylatoxin Receptors during the Effector Phase of Allergic Asthma Suppresses Airway Hyperresponsiveness and Airway Inflammation. J. Immunol. 174: 783-789 [Abstract] [Full Text]  
  • Grigg, J (2004). Management of paediatric asthma. Postgrad. Med. J. 80: 535-540 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.